Cancer Genetics, Inc.
Cancer Genetics, Inc., a leading player in the oncology-focused genetic testing industry, is headquartered in the United States. Founded in 2000, the company has established itself as a pioneer in providing advanced genomic testing services that aid in the diagnosis and management of cancer. With a strong presence across major operational regions in North America and Europe, Cancer Genetics, Inc. offers a comprehensive suite of products, including molecular diagnostics and genomic profiling. What sets Cancer Genetics apart is its commitment to precision medicine, utilising cutting-edge technology to deliver tailored insights for oncologists and patients alike. The company has achieved significant milestones, including partnerships with prominent healthcare institutions, solidifying its market position as a trusted provider of cancer-related genetic information. Through its innovative approach, Cancer Genetics, Inc. continues to make strides in improving patient outcomes in the fight against cancer.
DitchCarbon Score
How does Cancer Genetics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cancer Genetics, Inc.'s score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Cancer Genetics, Inc.'s reported carbon emissions
Cancer Genetics, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and climate commitments suggests that Cancer Genetics, Inc. may not have established formal initiatives to address its carbon footprint or align with industry standards for climate action. As the company operates within a sector increasingly focused on sustainability, it may benefit from developing and communicating clear climate strategies to enhance its environmental responsibility and transparency.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cancer Genetics, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
